Get the latest tech news
Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.
Eli Lilly’s 18-month trial included more than 3,000 adults with an average starting weight of 228 pounds and a body mass index of 37, which is considered obese. Eli Lilly says more detailed results will be presented in September at the European Association for the Study of Diabetes annual meeting and published in a peer-reviewed journal. In a recent study published in The New England Journal of Medicine, the pill lowered blood sugar levels and weight in people with type 2 diabetes.
Or read this on Wired
